Andrew X. Zhang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
This article reports the design, synthesis, and evaluation of a novel class of molecules of intermediate size (approximately 7000 Da), which possess both the targeting and effector functions of antibodies. These compounds—called synthetic antibody mimics targeting prostate cancer (SyAM-Ps)—bind simultaneously to prostate-specific membrane antigen and Fc(More)
  • 1